|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Profit (Loss) for the year before income tax and social contribution | |||||
| Adjustments to reconcile profit (Loss) to cash generated by operations: | |||||
| Depreciation and amortization | |||||
| Net exchange and monetary changes | |||||
| Results from acquisitions and divestments | |||||
| Financial charges | |||||
| Result of equity method investments | |||||
| Other income and expenditure | |||||
| Transmission revenues | |||||
| Construction cost – transmission | |||||
| Regulatory remeasurements – transmission contracts | |||||
| Operating provisions (reversals) | |||||
| Fixed and intangible assets write off | |||||
| Results from hedged debt and derivatives | |||||
| Other | |||||
| Adjustments to reconcile profit with cash generated by operations | |||||
| (Increases) / decreases in operating assets | |||||
| Accounts Receivable, net | |||||
| Reimbursement right | |||||
| Others | |||||
| (Accruals) / decreases in operating assets | |||||
| Increases / (decreases) in operating liabilities | |||||
| Suppliers | |||||
| Advances | |||||
| Payroll | |||||
| Regulatory fees | |||||
| Others | |||||
| Increases / (decreases) in operating liabilities | |||||
| Payment of interests | |||||
| Receipt of allowed annual revenue – RAP | |||||
| Receipt of dividends and interest on equity | |||||
| Payment of judicial contingencies | |||||
| Securities and restricted deposits | |||||
| Payment of income tax and social contribution | |||||
| Supplementary social security | |||||
| Net cash from operating activities of continuing operations | |||||
| Net cash provided by operating activities | |||||
| FINANCING ACTIVITIES | |||||
| Loans and borrowings obtained and debentures obtained | |||||
| Payment of loans and financing and debentures - principal | |||||
| Payment of dividends and interest on equity | |||||
| Payment to dissenting shareholders – merge of shares | |||||
| Repurchase of shares | |||||
| Payment of obligations with CDE and revitalization of basins - principal | |||||
| Payment of leases – principal | |||||
| Others | |||||
| Net cash from (used in) financing activities of continuing operations | |||||
| Net cash from (used in) financing activities | |||||
| INVESTING ACTIVITIES | |||||
| Receipt of loans and financing | |||||
| Receipt of financial charges | |||||
| Acquisition of property, plant and equipment | |||||
| Acquisition of intangible assets | |||||
| Marketable Securities, net | |||||
| Interest Received - Marketable Securities | |||||
| Acquisition of Debentures | |||||
| Transmission infrastructure – contractual asset | |||||
| Acquisition / capital injection in shareholdings, net of cash acquired | |||||
| Receipt from disposal/acquisition of assets | |||||
| Acquisition of subsidiary, net of cash acquired | |||||
| Other | |||||
| Net cash used in investing activities of continuing operations | |||||
| Net cash provided by investing in activities of discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Decrease/Increase in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the fiscal year | |||||
| Cash and cash equivalents at the end of the year | |||||
| Increase in cash and cash equivalents from discontinued operations | |||||
Loading...